MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

Search

NeoGenomics Inc

Uždarymo kaina

6.24 -6.73

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

6.21

Max

6.65

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-11M

-26M

Pardavimai

-4M

168M

Pelno marža

-15.427

Darbuotojai

2,200

EBITDA

-10M

-6.3M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+59.97% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-07-29

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-359M

924M

Ankstesnė atidarymo kaina

12.97

Ankstesnė uždarymo kaina

6.24

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

NeoGenomics Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-07-18 14:33; UTC

Pagrindinės rinkos jėgos

MEI Pharma Stock Surges on $100 Million Private Placement, Litecoin Treasury Strategy

2025-07-17 21:14; UTC

Įsigijimai, susijungimai, perėmimai

Basel Medical Group Puts $1 Billion Bitcoin Purchase on Hold

2025-07-17 18:49; UTC

Įsigijimai, susijungimai, perėmimai

Bitcoin Standard Treasury to Go Public Via SPAC Deal

2025-07-14 17:06; UTC

Pagrindinės rinkos jėgos

Crypto Assets Rally Ahead of Possible U.S. Legislation

2025-07-18 14:31; UTC

Rinkos pokalbiai

U.S. Regulation is Driving Crypto Demand -- Market Talk

2025-07-18 14:18; UTC

Pagrindinės rinkos jėgos

MEI Pharma Stock Surges on $100M Private Placement, Litecoin Treasury Strategy

2025-07-18 07:06; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-07-18 07:06; UTC

Rinkos pokalbiai

Bitcoin Rises on Optimism Over U.S. Regulation -- Market Talk

2025-07-17 21:45; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-07-17 21:45; UTC

Rinkos pokalbiai

Crypto Bills Welcomed by Venture Capital, Trade Group Says -- Market Talk

2025-07-17 20:59; UTC

Įsigijimai, susijungimai, perėmimai

Basel Medical Group Puts $1B Bitcoin Purchase on Hold

2025-07-17 14:37; UTC

Rinkos pokalbiai

Ethereum Outperforms as Bitcoin Stays Stuck Below $120,000 -- Market Talk

2025-07-17 13:06; UTC

Įsigijimai, susijungimai, perėmimai

Cantor Equity Partners I, Upon Closing, Combined Company Expected to Trade Under Ticker Symbol BSTR >CEPO

2025-07-17 13:06; UTC

Įsigijimai, susijungimai, perėmimai

Bitcoin Standard Treasury to Go Public Through Business Combination With Cantor Equity Partners I

2025-07-17 09:19; UTC

Rinkos pokalbiai

Bitcoin Falls, Stays at High Levels Amid Focus on U.S. Legislation -- Market Talk

2025-07-17 09:19; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-07-16 13:41; UTC

Įsigijimai, susijungimai, perėmimai

This Crypto Stock Is Soaring. Peter Thiel Just Made a Big Bet. -- Barrons.com

2025-07-16 11:16; UTC

Įsigijimai, susijungimai, perėmimai

This Crypto Stock Soared 30%. Peter Thiel Just Made a Big Bet. -- Barrons.com

2025-07-16 09:05; UTC

Rinkos pokalbiai

Bitcoin Turns Higher Again Ahead of Possible U.S. Legislation -- Market Talk

2025-07-15 15:15; UTC

Rinkos pokalbiai

Sovereign Adoption of Bitcoin is Rising -- Market Talk

2025-07-15 14:40; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-07-15 14:40; UTC

Rinkos pokalbiai

Stablecoins Aren't a Long-Term Store of Value -- Market Talk

2025-07-15 14:05; UTC

Rinkos pokalbiai

Investors More Sensitive to Risk of Crypto Collapse -- Market Talk

2025-07-15 13:20; UTC

Rinkos pokalbiai

Bitcoin's Recent Rally Could Extend Further -- Market Talk

2025-07-15 13:20; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-07-15 12:42; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-07-15 12:42; UTC

Rinkos pokalbiai

Widespread Bitcoin Adoption Is Still Some Way Off -- Market Talk

2025-07-15 08:22; UTC

Rinkos pokalbiai

Bitcoin Hit by Profit-Taking After Surge to Record Highs -- Market Talk

2025-07-14 15:54; UTC

Rinkos pokalbiai

Market Talk Roundup: Latest on U.S. Politics

2025-07-14 15:54; UTC

Rinkos pokalbiai

'Crypto Week' Legislation Would Overhaul U.S. Crypto Policy -- Market Talk

Akcijų palyginimas

Kainos pokytis

NeoGenomics Inc Prognozė

Kainos tikslas

By TipRanks

59.97% į viršų

12 mėnesių prognozė

Vidutinis 10.75 USD  59.97%

Aukščiausias 12 USD

Žemiausias 8.5 USD

Remiantis 10 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines NeoGenomics Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

10 ratings

6

Pirkti

4

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

7.7 / 10.27Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bearish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Bearish Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.